Tweenvest Stocks

Shanghai Shyndec Pharmaceutical Co., Ltd. (SHSE: 600420)

Health Care · Pharmaceuticals · CN

CN¥8.46

-3.09% today · -26.1% 1Y

Shanghai Shyndec Pharmaceutical Co., Ltd. (SHSE: 600420) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.69B and employs 9,697 people.

Over the last twelve months the share price has lost 26.1%, trading between 7.67 and 11.78.

Tweenvest scores Shanghai Shyndec Pharmaceutical Co., Ltd. across four factors: quality 78/100, value 56/100, growth 15/100, dividend 60/100. Its strongest factor is quality.

600420 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.69B
Revenue (TTM)
$1.28B
P/E
15.79
EPS
0.54
Dividend yield
3.55%
Beta (5Y)
0.09
52-week high
CN¥11.78
52-week low
CN¥7.67
Avg volume (3M)
Shares outstanding
1.34B
Employees
9,697
Next earnings

About Shanghai Shyndec Pharmaceutical Co., Ltd.

Shanghai Shyndec Pharmaceutical Co., Ltd., established in 1996 and headquartered in Shanghai, China, operates as a pharmaceutical enterprise. The company focuses on the global production of various drug formulations. Its primary therapeutic areas of specialization include anti-infectives, cardiovascular and cerebrovascular treatments, oncology, metabolic disorders, and endocrine system conditions.

ISIN
CNE000001JG2
Founded
1996
Listed since
Jun 16, 2004
Exchange
Shanghai Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.12T$1,255.40+0.88%
Johnson & JohnsonNYSE: JNJ$651.25B$270.24+1.07%
Merck & Co., Inc.NYSE: MRK$376.37B$152.55+2.39%
Roche Holding AGSWX: ROP$373.91BCHF375.60+1.02%
Novartis AGSWX: NOVN$302.17BCHF127.42+0.85%
AstraZeneca PLCLSE: AZN$258.76B£122.40+1.26%
Novo Nordisk A/SCPSE: NOVO B$207.84BDkr300.85+1.59%
Pfizer Inc.NYSE: PFE$159.99B$28.07+1.01%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.